Cargando…
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
BACKGROUND: α-Synuclein (α-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of α-synucleinopathies, such as Parkinson’s disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, a...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150548/ https://www.ncbi.nlm.nih.gov/pubmed/33579871 http://dx.doi.org/10.3233/JPD-202351 |
_version_ | 1783698177798438912 |
---|---|
author | George, Sonia Tyson, Trevor Rey, Nolwen L. Sheridan, Rachael Peelaerts, Wouter Becker, Katelyn Schulz, Emily Meyerdirk, Lindsay Burmeister, Amanda R. von Linstow, Christian U. Steiner, Jennifer A. Galvis, Martha L. Escobar Ma, Jiyan Pospisilik, J. Andrew Labrie, Viviane Brundin, Lena Brundin, Patrik |
author_facet | George, Sonia Tyson, Trevor Rey, Nolwen L. Sheridan, Rachael Peelaerts, Wouter Becker, Katelyn Schulz, Emily Meyerdirk, Lindsay Burmeister, Amanda R. von Linstow, Christian U. Steiner, Jennifer A. Galvis, Martha L. Escobar Ma, Jiyan Pospisilik, J. Andrew Labrie, Viviane Brundin, Lena Brundin, Patrik |
author_sort | George, Sonia |
collection | PubMed |
description | BACKGROUND: α-Synuclein (α-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of α-synucleinopathies, such as Parkinson’s disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, as well as the activation of T and B cells. These immune changes point towards a dysregulation of both the innate and the adaptive immune system. T cells have been shown to recognize epitopes derived from α-syn and altered populations of T cells have been found in PD and MSA patients, providing evidence that these cells can be key to the pathogenesis of the disease. OBJECTIVE: To study the role of the adaptive immune system with respect to α-syn pathology. METHODS: We injected human α-syn preformed fibrils (PFFs) into the striatum of immunocompromised mice (NSG) and assessed accumulation of phosphorylated α-syn pathology, proteinase K-resistant α-syn pathology and microgliosis in the striatum, substantia nigra and frontal cortex. We also assessed the impact of adoptive transfer of naïve T and B cells into PFF-injected immunocompromised mice. RESULTS: Compared to wildtype mice, NSG mice had an 8-fold increase in phosphorylated α-syn pathology in the substantia nigra. Reconstituting the T cell population decreased the accumulation of phosphorylated α-syn pathology and resulted in persistent microgliosis in the striatum when compared to non-transplanted mice. CONCLUSION: Our work provides evidence that T cells play a role in the pathogenesis of experimental α-synucleinopathy. |
format | Online Article Text |
id | pubmed-8150548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-81505482021-05-26 T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils George, Sonia Tyson, Trevor Rey, Nolwen L. Sheridan, Rachael Peelaerts, Wouter Becker, Katelyn Schulz, Emily Meyerdirk, Lindsay Burmeister, Amanda R. von Linstow, Christian U. Steiner, Jennifer A. Galvis, Martha L. Escobar Ma, Jiyan Pospisilik, J. Andrew Labrie, Viviane Brundin, Lena Brundin, Patrik J Parkinsons Dis Research Report BACKGROUND: α-Synuclein (α-syn) is the predominant protein in Lewy-body inclusions, which are pathological hallmarks of α-synucleinopathies, such as Parkinson’s disease (PD) and multiple system atrophy (MSA). Other hallmarks include activation of microglia, elevation of pro-inflammatory cytokines, as well as the activation of T and B cells. These immune changes point towards a dysregulation of both the innate and the adaptive immune system. T cells have been shown to recognize epitopes derived from α-syn and altered populations of T cells have been found in PD and MSA patients, providing evidence that these cells can be key to the pathogenesis of the disease. OBJECTIVE: To study the role of the adaptive immune system with respect to α-syn pathology. METHODS: We injected human α-syn preformed fibrils (PFFs) into the striatum of immunocompromised mice (NSG) and assessed accumulation of phosphorylated α-syn pathology, proteinase K-resistant α-syn pathology and microgliosis in the striatum, substantia nigra and frontal cortex. We also assessed the impact of adoptive transfer of naïve T and B cells into PFF-injected immunocompromised mice. RESULTS: Compared to wildtype mice, NSG mice had an 8-fold increase in phosphorylated α-syn pathology in the substantia nigra. Reconstituting the T cell population decreased the accumulation of phosphorylated α-syn pathology and resulted in persistent microgliosis in the striatum when compared to non-transplanted mice. CONCLUSION: Our work provides evidence that T cells play a role in the pathogenesis of experimental α-synucleinopathy. IOS Press 2021-04-13 /pmc/articles/PMC8150548/ /pubmed/33579871 http://dx.doi.org/10.3233/JPD-202351 Text en © 2021 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Report George, Sonia Tyson, Trevor Rey, Nolwen L. Sheridan, Rachael Peelaerts, Wouter Becker, Katelyn Schulz, Emily Meyerdirk, Lindsay Burmeister, Amanda R. von Linstow, Christian U. Steiner, Jennifer A. Galvis, Martha L. Escobar Ma, Jiyan Pospisilik, J. Andrew Labrie, Viviane Brundin, Lena Brundin, Patrik T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils |
title | T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils |
title_full | T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils |
title_fullStr | T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils |
title_full_unstemmed | T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils |
title_short | T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils |
title_sort | t cells limit accumulation of aggregate pathology following intrastriatal injection of α-synuclein fibrils |
topic | Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150548/ https://www.ncbi.nlm.nih.gov/pubmed/33579871 http://dx.doi.org/10.3233/JPD-202351 |
work_keys_str_mv | AT georgesonia tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT tysontrevor tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT reynolwenl tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT sheridanrachael tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT peelaertswouter tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT beckerkatelyn tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT schulzemily tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT meyerdirklindsay tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT burmeisteramandar tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT vonlinstowchristianu tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT steinerjennifera tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT galvismarthalescobar tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT majiyan tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT pospisilikjandrew tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT labrieviviane tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT brundinlena tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils AT brundinpatrik tcellslimitaccumulationofaggregatepathologyfollowingintrastriatalinjectionofasynucleinfibrils |